key: cord-0880794-fqqlgidg authors: Hsu, Lea; Wisplinghoff, Hilmar; Kossow, Annelene; Hurraß, Julia; Wiesmüller, Gerhard A.; Grüne, Barbara; Hoffmann, Dennis; Lüsebrink, Jessica; Demuth, Sabrina; Schildgen, Oliver; Schildgen, Verena title: Limited protection against SARS-CoV-2 infection and virus transmission after mRNA vaccination date: 2021-06-29 journal: J Infect DOI: 10.1016/j.jinf.2021.06.023 sha: c13709d0383a2ddfaec88004563381d8dacd7964 doc_id: 880794 cord_uid: fqqlgidg nan Lea Hsu 1 , Hilmar Wisplinghoff, MD 2,3 , AnneleneKossow, MD, PhD 1,4 , Julia Hurraß, PhD 1 , Gerhard A. Wiesmüller, MD 1 , Barbara Grüne, MD 1 , Dennis Hoffmann, PhD 2 , Jessica Lüsebrink, PhD 5 , Sabrina Demuth, MSc 5 , Oliver Schildgen, PhD 3,5 , VerenaSchildgen, PhD 5 Affiliations: 1 . Stang and coworkers have recently reported in the Journal that "RT-PCR test results as gold standard for assessing and controlling infectiousness fail" (1). The authors analyzed two scenarios and used Ct25 and Ct30 as thresholds for infectiousness and conclude that more than the half of their patient cohort was unlikely to have been infectious, i.e. the group of patients tested positive at Ct values >25 or >30. While we agree that Ct values are insufficient to determine the infectiousness we would like to add that also for the cohort of vaccinated individuals the Ct values are rather misleading. As shown in an early released study vaccinated people can not only become infected with SARS-CoV-2 but the virus can successfully be isolated by cell culture approaches, at least for a shorter time slot as in unvaccinated people (2) . Thereby, the viral loads as determined by the Ct values do not significantly differ between vaccinated and unvaccinated cohorts. While the group from Berlin analyzed an outbreak with the alpha variant, we made similar observations, also including the wild type strain. In their recent report, Liu and coworkers demonstrated neutralization of newly emerged SARS-CoV-2 variants after properly completed BNT162b2 vaccination (3) and referred to a previous publication, which already showed neutralizing of the B.1.1.7 variant (4). Although determination of SARS-CoV-2 vaccination success, at least as antibody titre (arbitrary units / ml), is not part of the actual vaccination campaign, a vaccineinduced immune response in up to 92% cases must be assumed (8) . Nevertheless, studies on overall neutralizing capacity do not take into account effects like specific T-cell release, heterogeneous antibody populations, or the occurrence of non-spike mutations influencing viral replication and immune response, which was also discussed by Liu et al. (3) . Another effect that should also be considered is the general non-lasting triggering of the innate immunity by contact with foreign RNA (9) (10) (11) . This may explain why vaccination based neutralizing effects in some cases seem to be less sustained than assumed. In this context the "green passport", which is still considered in Europe and Israel, is just a vaccination certificate not more, not less. The individual risk for severe/life threatening COVID-19 may be significantly reduced although fatal courses remain possible, but it must be taken into account that any vaccinated individual may become an, at least short term, spreader of the virus. The performance of the SARS-CoV-2 RT-PCR test as a tool for detecting SARS-CoV-2 infection in the population Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants Neutralizing Activity of BNT162b2-Elicited Serum. The New England journal of medicine SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes Respiratory syncytial virus infection in older persons Vaccine in a Nationwide Mass Vaccination Setting. The New England journal of medicine Recognition of viral nucleic acids in innate immunity Recognition of nucleic acids by pattern-recognition receptors and its relevance in autoimmunity Role of DNA/RNA sensors and contribution to autoimmunity